- Home
- CLPS vs ANVS Comparison
CLPS vs ANVS Comparison
Compare CLPS & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPS
- ANVS
- Stock Information
- Founded
- CLPS 2005
- ANVS 2008
- Country
- CLPS Hong Kong
- ANVS United States
- Employees
- CLPS N/A
- ANVS N/A
- Industry
- CLPS Computer Software: Prepackaged Software
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- CLPS Technology
- ANVS Health Care
- Exchange
- CLPS Nasdaq
- ANVS Nasdaq
- Market Cap
- CLPS 26.6M
- ANVS 24.2M
- IPO Year
- CLPS 2018
- ANVS 2020
- Fundamental
- Price
- CLPS $0.99
- ANVS $1.53
- Analyst Decision
- CLPS
- ANVS Strong Buy
- Analyst Count
- CLPS 0
- ANVS 4
- Target Price
- CLPS N/A
- ANVS $40.67
- AVG Volume (30 Days)
- CLPS 5.8K
- ANVS 460.8K
- Earning Date
- CLPS 03-05-2025
- ANVS 05-20-2025
- Dividend Yield
- CLPS 12.87%
- ANVS N/A
- EPS Growth
- CLPS N/A
- ANVS N/A
- EPS
- CLPS N/A
- ANVS N/A
- Revenue
- CLPS $153,816,045.00
- ANVS N/A
- Revenue This Year
- CLPS N/A
- ANVS N/A
- Revenue Next Year
- CLPS N/A
- ANVS N/A
- P/E Ratio
- CLPS N/A
- ANVS N/A
- Revenue Growth
- CLPS 5.81
- ANVS N/A
- 52 Week Low
- CLPS $0.68
- ANVS $1.11
- 52 Week High
- CLPS $1.70
- ANVS $17.88
- Technical
- Relative Strength Index (RSI)
- CLPS 46.05
- ANVS 49.17
- Support Level
- CLPS $0.94
- ANVS $1.42
- Resistance Level
- CLPS $1.00
- ANVS $1.75
- Average True Range (ATR)
- CLPS 0.03
- ANVS 0.16
- MACD
- CLPS 0.00
- ANVS 0.03
- Stochastic Oscillator
- CLPS 56.92
- ANVS 43.59
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.